home / stock / evo / evo news


EVO News and Press, Evotec SE From 11/05/25

Stock Information

Company Name: Evotec SE
Stock Symbol: EVO
Market: NASDAQ
Website: evotec.com

Menu

EVO EVO Quote EVO Short EVO News EVO Articles EVO Message Board
Get EVO Alerts

News, Short Squeeze, Breakout and More Instantly...

EVO - Expected US Company Earnings on Wednesday, November 5th, 2025

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

EVO - Expected earnings - Evotec SE

Evotec SE (EVO) is expected to report $-0.14 for Q3 2025

EVO - Evotec SE reports Q3 results

2025-11-05 03:29:12 ET More on Evotec SE Evotec SE (EVO) Q2 2025 Earnings Call Transcript Evotec SE 2025 Q2 - Results - Earnings Call Presentation Evotec SE reports 1H results Seeking Alpha’s Quant Rating on Evotec SE Historical earnings data f...

EVO - Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD business Strong scientific advancements o...

EVO - In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

Transaction showcases Evotec's unique capability enabling customers to produce biologics faster and at lower costs through its continuous manufacturing technology Accelerated implementation of strategy through better monetization of technology and transitioning to an asset-lighter business...

EVO - Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025. The Company is going to hold...

EVO - Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Advances made in preclinical pipeline addressing neurodegenerative diseases Evotec receives US$ 25 m payment to support continued progression of joint programs HAMBURG, DE / ACCESS Newswire / October 27, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard...

EVO - EVO Price Target Alert: $7.00. Issued by H.C. Wainwright

2025-08-14 08:10:11 ET Douglas Tsao from H.C. Wainwright issued a price target of $7.00 for EVO on 2025-08-14 10:04:33. The adjusted price target was set to $7.00. At the time of the announcement, EVO was trading at $3.81. The overall price target consensus is at $8.00 w...

EVO - Expected US Company Earnings on Wednesday, August 13th, 2025

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

EVO - Evotec SE to announce first half-year results 2025 on 13 August 2025

HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its half-year interim report for the first six months of 2025 on Wednesday, 13 August 2025. The Company is going to ...

Previous 10 Next 10